In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange that the Board of Directors of the Company at their meeting held on Saturday, 14th November 2026. The Meeting of the Board of Directors of the Company was commenced at 12.00 Noon and concluded at 02:00 P.M.

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai‐ 400001 Scrip code‐ 524202 Subject: Outcome of Board Meeting. Dear Sir, In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange that the Board of Directors of the Company at their meeting held on Saturday, 14th November 2026 has, inter alia, considered and approved the followings items of agenda: 1. Un‐audited Financial Results along with the Limited Review Report issued by the Statutory Auditor of the Company for the Second quarter and half year ended 30th September, 2026. A copy of the aforesaid Un‐Audited Financial Results along with the Limited Review Report is enclosed herewith. 2. Allotment of 15,89,200 (Fifteen Lakh Eighty-Nine Thousand Two Hundred) fully paid‐up equity shares of face value INR 10/‐ each of the Company to the eligible equity shareholders of Vitanosh Ingredients Private Limited (“Transferor Company”) as on the Record Date i.e. November 02, 2026 in accordance with the approved share exchange ratio specified under the Scheme, i.e., 0.7946 (zero decimal seventy nine forty six) equity shares of Lactose (India) Limited (“Transferee Company”) for every 1 (One) equity shares held in the Transferor Company. Consequent to the above allotment, the issued, subscribed and paid‐up equity share capital of the Company stands increased from INR 12,58,90,000/‐, comprising of 1,25,89,000 equity shares of face value INR 10/‐ each, to INR 14,17,82,000/‐, comprising of 1,41,78,200 equity shares of face value INR 10/‐ each. The equity shares allotted as aforesaid shall rank pari passu in all respects with the existing equity shares of the Company and shall be listed on BSE Limited in compliance with the relevant provisions of the Listing Regulations and other applicable laws. The Meeting of the Board of Directors of the Company commenced at 12:00 noon and concluded at 02:00 P.M. Kindly take the same on record and oblige. FOR LACTOSE (INDIA) LIMITED Atul Maheshwari Managing Director DIN: 00255202 Date: 14th November, 2026 Place: Mumbai Encl: As above Independent Auditor’s Limited Review Report on Unaudited Financial Results of Lactose (India) Limited for the quarter and half year ended on September 30, 2026, pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors of Lactose India Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Lactose India Limited (‘the Company’) for the quarter ended September 30, 2026 and year to date from April 01, 2026 to September 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulation’). 2. This Statement, which is the responsibility of the Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’ (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other recognized accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether financial results are free of material misstatements. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other recognized accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulation including the manner in which it is to be disclosed, or that it contains any material misstatement. Emphasis of Matter Paragraph 1. We draw attention to Note 3 to the Statement of Unaudited Financial Results, which describes the Scheme of Amalgamation between Vitanosh Ingredients Private Limited (“Transferor Company”) and Lactose (India) Limited (“Transferee Company”), sanctioned by the Hon’ble National Company Law Tribunal, vide its order dated August 5th, 2026, with an Appointed Date of October 1, 2024, and which became effective on September 5th , 2026. As explained in the aforesaid note, the corresponding previous-period figures have been restated to give effect to the amalgamation. Our conclusion is not modified in respect of this matter. For D M K H & Co Chartered Accountants Firm’s Registration No. 116886W Shikha Kabra Partner Mem. No. 179437 UDIN: 26179437XYZLMA5196 Place: Mumbai Date: November 14, 2026 LACT: INDIA LIMITED LACTOSE (INDIA) LIMITED CIN: L15201GJ1991PLCO15186 Regd. Off. : Survey No.5, 6 & 7A, Village Poicha (Rania), Taluka Savii, District Vadodara, Gujarat - 391780 website :-www.lactoseindialimited.com, Email ID: li@lactoseindialimited.com, Telephone: 02246644333 Statement of Unaudited Financial Results for the Quarter and Half year ended 30th September 2026 (Rs. In Lakhs Except for EPS) 1|Revenue from operations O[R te hv ee rn Iu ne f or mo em operations 5,819.38 4,696.84 411813 10,516.22 8,075.69 16,329.01 209 38.14 2847 6023 58.32 66.87 Total income 5,841.47 4,734.98 4,146.60 10,576.44 8,134.01 16,395.88 2|Expenses (a) Cost of materials consumed 3,888.76 3,249.18 222967 7,137.94 3,792.88 8,751.59 (b) Change in inventories of finished goods, work-in-progress and stock-in-frade 511 (613.46) 7255 (608.35) 836.38 676.67 (c) Manufacturing Expenses 74261 790.18 706.90 1,532.80 1,330.09 257409 (d) Employees benefits expenses 41213 42513 359.40 831.26 710.24 1430.98 (e) Finance Costs 21384 164.46 98.89 37831 21764 483.96 (f) Depreciation and amortization expenses 18267 183.03 163.57 365.71 32013 661.52 (g) Other expenses 311.04 271.03 239.83 58207 465,86 1,124.89 Total Expenses 5756.16 446956 387082 1022574 767322 15,693.70 3| Profit(Loss) before tax 8531 265.43 27578 35074 460.79 70218 4|Tax Expense: Current Tax (net) 291 9.07 47.06 11.98 7863 119.82 Deferred Tax (net) 37.83 11775 46,07 155.57 86.88 98.98 Tax of Earlier Years - - - - - (22.13)] 5{Net Profit/(loss) after tax 44.57 138.61 182.67 183.16 29528 505.51 6|Other Comprehensive Incomel(loss) Items That will not be reclassified subsequently into Profit or loss Remeasurements of Defined Benefits Plan (Net of Tax) - * “ - - (1.03)] Income tax effect - - - - < 031 7|Total Comprehensive income/(loss),net of tax (5+6) 44.57) 138.61 182.67 183.16 20528 504.79 Paid-up equity share capital (Face Value of Rs. 10 each) 1,258.90 1,258.90 1,258.90 1,258.90 1,258.90 1,258.90 9| Other Equity(excluding revaluation reserve) - - - - - 4,961.25 10[Earnings per share (of Rs. 10/- each) (not annualised for the quarters) (a) Basic (inRs.) 031 098 129 129 (b) Dilut [Showing first 8,000 characters — download PDF for full document]